135 related articles for article (PubMed ID: 30180735)
1. Predictors of dyspnea in patients with advanced cancer.
McKenzie E; Hwang MK; Chan S; Zhang L; Zaki P; Tsao M; Barnes E; Razvi Y; Drost L; Yee C; Chow E
Ann Palliat Med; 2018 Oct; 7(4):427-436. PubMed ID: 30180735
[TBL] [Abstract][Full Text] [Related]
2. Symptom correlates of dyspnea in advanced cancer patients using the Edmonton Symptom Assessment System.
McKenzie E; Zhang L; Chan S; Zaki P; Razvi Y; Tsao M; Barnes E; Drost L; Yee C; Hwang M; DeAngelis C; Chow E
Support Care Cancer; 2020 Jan; 28(1):87-98. PubMed ID: 30982093
[TBL] [Abstract][Full Text] [Related]
3. Impact of dyspnea on advanced cancer patients referred to a palliative radiotherapy clinic.
Rowbottom L; Chan S; Zhang L; McDonald R; Barnes E; Tsao M; Zaki P; Chow E
Support Care Cancer; 2017 Sep; 25(9):2691-2696. PubMed ID: 28341970
[TBL] [Abstract][Full Text] [Related]
4. Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System.
Zeng L; Koo K; Zhang L; Jon F; Dennis K; Holden L; Nguyen J; Tsao M; Barnes E; Danjoux C; Sahgal A; Chow E
Support Care Cancer; 2012 May; 20(5):1037-42. PubMed ID: 21538097
[TBL] [Abstract][Full Text] [Related]
5. Impact of a Specialized Ambulatory Clinic on Refractory Breathlessness in Subjects With Advanced COPD.
Elbehairy AF; McIsaac H; Hill E; Norman PA; Day AG; Neder JA; O'Donnell DE; Harle IA
Respir Care; 2020 Apr; 65(4):444-454. PubMed ID: 31719189
[TBL] [Abstract][Full Text] [Related]
6. Impact of outpatient palliative care (PC) on symptom burden in patients with advanced cancer at a tertiary cancer center in Jordan.
Shamieh O; Khamash O; Khraisat M; Jbouri O; Awni M; Al-Hawamdeh A; Arja G; Ajarmeh S; Al-Rimawi D; Hui D
Support Care Cancer; 2017 Jan; 25(1):177-183. PubMed ID: 27604806
[TBL] [Abstract][Full Text] [Related]
7. Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.
Tjong MC; Doherty M; Tan H; Chan WC; Zhao H; Hallet J; Darling G; Kidane B; Wright FC; Mahar A; Davis LE; Delibasic V; Parmar A; Mittmann N; Coburn NG; Louie AV
Oncologist; 2021 Oct; 26(10):e1800-e1811. PubMed ID: 34216415
[TBL] [Abstract][Full Text] [Related]
8. Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.
Yogananda MN; Muthu V; Prasad KT; Kohli A; Behera D; Singh N
Support Care Cancer; 2018 Mar; 26(3):767-775. PubMed ID: 29027005
[TBL] [Abstract][Full Text] [Related]
9. Patient-Reported Symptom Severity Among 22,650 Cancer Outpatients in the Last Six Months of Life.
Bubis LD; Davis LE; Canaj H; Gupta V; Jeong Y; Barbera L; Li Q; Moody L; Karanicolas PJ; Sutradhar R; Coburn NG; Mahar AL
J Pain Symptom Manage; 2020 Jan; 59(1):58-66.e4. PubMed ID: 31430522
[TBL] [Abstract][Full Text] [Related]
10. Edmonton symptom assessment scale: Italian validation in two palliative care settings.
Moro C; Brunelli C; Miccinesi G; Fallai M; Morino P; Piazza M; Labianca R; Ripamonti C
Support Care Cancer; 2006 Jan; 14(1):30-7. PubMed ID: 15937688
[TBL] [Abstract][Full Text] [Related]
11. Self-reported sleep disturbance in patients with advanced cancer: Frequency, intensity, and factors associated with response to outpatient supportive care consultation--A preliminary report.
Yennurajalingam S; Chisholm G; Palla SL; Holmes H; Reuben JM; Bruera E
Palliat Support Care; 2015 Apr; 13(2):135-43. PubMed ID: 24182896
[TBL] [Abstract][Full Text] [Related]
12. Severe symptoms persist for Up to one year after diagnosis of stage I-III lung cancer: An analysis of province-wide patient reported outcomes.
Hirpara DH; Gupta V; Davis LE; Zhao H; Hallet J; Mahar AL; Sutradhar R; Doherty M; Louie AV; Kidane B; Darling G; Coburn NG
Lung Cancer; 2020 Apr; 142():80-89. PubMed ID: 32120228
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for well-being in advanced cancer patients referred for palliative radiotherapy.
Lien K; Zeng L; Zhang L; Nguyen J; Di Giovanni J; Popovic M; Jamani R; Cramarossa G; Culleton S; Chow E
Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):443-51. PubMed ID: 22794326
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported symptoms before palliative radiotherapy predict survival differences.
Nieder C; Kämpe TA; Pawinski A; Dalhaug A
Strahlenther Onkol; 2018 Jun; 194(6):533-538. PubMed ID: 29344766
[TBL] [Abstract][Full Text] [Related]
15. Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the Lung Cancer Symptom Scale in a community hospital.
Lutz S; Norrell R; Bertucio C; Kachnic L; Johnson C; Arthur D; Schwarz M; Palardy G
J Palliat Med; 2001; 4(2):157-65. PubMed ID: 11441624
[TBL] [Abstract][Full Text] [Related]
16. What bothers lung cancer patients the most? A prospective, longitudinal electronic patient-reported outcomes study in advanced non-small cell lung cancer.
LeBlanc TW; Nickolich M; Rushing CN; Samsa GP; Locke SC; Abernethy AP
Support Care Cancer; 2015 Dec; 23(12):3455-63. PubMed ID: 25791391
[TBL] [Abstract][Full Text] [Related]
17. Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study.
Kulich K; Keininger DL; Tiplady B; Banerji D
Int J Chron Obstruct Pulmon Dis; 2015; 10():79-94. PubMed ID: 25609942
[TBL] [Abstract][Full Text] [Related]
18. Personalized Goal for Dyspnea and Clinical Response in Advanced Cancer Patients.
Mercadante S; Adile C; Aielli F; Lanzetta G; Mistakidou K; Maltoni M; Soares LG; De Santis S; Ferrera P; Rosati M; Rossi R; Casuccio A
J Pain Symptom Manage; 2019 Jan; 57(1):79-85. PubMed ID: 30336213
[TBL] [Abstract][Full Text] [Related]
19. Dyspnea experience in patients with lung cancer in palliative care.
Henoch I; Bergman B; Gustafsson M; Gaston-Johansson F; Danielson E
Eur J Oncol Nurs; 2008 Apr; 12(2):86-96. PubMed ID: 18023256
[TBL] [Abstract][Full Text] [Related]
20. Does Patient-reported Dyspnea Reflect Thoracic Disease Characteristics in Patients with Incurable Cancer?
Nieder C; Kämpe TA; Engljähringer K
Anticancer Res; 2018 Feb; 38(2):901-904. PubMed ID: 29374718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
